Company Filing History:
1 out of 468 
Years Active: 1993-2025
Title: Eric Rudolph: Innovator in Chemical Manufacturing
Introduction
Eric Rudolph is an accomplished inventor based in Ambler, PA (US). He holds a total of 2 patents that contribute significantly to the field of chemical manufacturing, particularly in biopharmaceuticals. His innovative approaches have paved the way for advancements in the industry.
Latest Patents
Rudolph's latest patents include a focus on disposable containers and reaction systems. The first patent relates to equipment utilized to manufacture chemical agents, specifically biopharmaceuticals, using Disposable Containers (DCs). These containers are designed for storing and supplying buffers and other solutions in systems for carrying out reactions in reaction vessels. The design includes a first and second end, with one or more attachment connectors at the first end and one or more conveyance connectors at the second end. The second patent involves a process for recovering a solid component from a solid composition by clarification and extraction in a common apparatus. This process allows for the recovery of a solid component admixed with an aqueous medium, utilizing an organic solvent that is clarified in the apparatus by filtration with a filter that is not degraded by the organic solvent.
Career Highlights
Eric Rudolph is currently employed at Millipore Corporation, where he continues to innovate and develop new technologies in the field. His work has been instrumental in enhancing the efficiency and effectiveness of chemical manufacturing processes.
Collaborations
Rudolph has collaborated with notable coworkers, including Chris Antoniou and Gaston De Los Reyes. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in their field.
Conclusion
Eric Rudolph's contributions to the field of chemical manufacturing through his patents and collaborations highlight his role as a significant innovator. His work continues to influence the industry and drive advancements in biopharmaceutical manufacturing.